GAIA BioMedicine

Fukuoka, Japan

GAIA BioMedicine is a biopharmaceutical company that specializes in innovative cell therapies and immunotherapies for treating solid tumors.

Sep 2021

Series B

Biotechnology Management Consulting Pharmaceutical Therapeutics

Top Investors

SBI InvestmentOsaka University Venture CapitalCEJ CapitalHisamitsu Pharmaceutical

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GAIA BioMedicine

Who are GAIA BioMedicine's investors?

GAIA BioMedicine's investors include SBI Investment, Osaka University Venture Capital, CEJ Capital, Hisamitsu Pharmaceutical.

Where is GAIA BioMedicine headquartered?

GAIA BioMedicine is headquartered in Fukuoka, Japan.

What does GAIA BioMedicine do?

GAIA BioMedicine is a biopharmaceutical company that specializes in innovative cell therapies and immunotherapies for treating solid tumors.

What stage is GAIA BioMedicine at?

GAIA BioMedicine is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2021.

MLA

"GAIA BioMedicine — Funding & Investors." VCBacked, September 21, 2021, https://www.vcbacked.co/company/gaia-biomedicine. Accessed July 1, 2026.

APA

VCBacked. (2021). GAIA BioMedicine — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gaia-biomedicine

Wikipedia (cite web)

{{cite web |title=GAIA BioMedicine — Funding & Investors |url=https://www.vcbacked.co/company/gaia-biomedicine |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.